Patients with ES-SCLC show significantly higher number of CD56+ CTC compared with patient diagnosed with LS-SCLC (respective median of 7.95 vs. 2.00; p = 0.014) (Fig. 3A). The gene discussed is NCAM1; the disease is small cell lung carcinoma.